Pathogenesis of human cytomegalovirus in the immunocompromised host
P Griffiths, M Reeves - Nature Reviews Microbiology, 2021 - nature.com
Human cytomegalovirus (HCMV) is a herpesvirus that infects~ 60% of adults in developed
countries and more than 90% in developing countries. Usually, it is controlled by a vigorous …
countries and more than 90% in developing countries. Usually, it is controlled by a vigorous …
The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …
complications affecting solid organ transplant recipients, conveying higher risks of …
Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation
FM Marty, P Ljungman, RF Chemaly… - … England Journal of …, 2017 - Mass Medical Soc
Background Cytomegalovirus (CMV) infection remains a common complication after
allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the …
allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the …
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European …
P Ljungman, R de la Camara, C Robin… - The Lancet infectious …, 2019 - thelancet.com
Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …
Approved antiviral drugs over the past 50 years
E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …
categorized into 13 functional groups have been formally approved for the treatment of the …
Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials
P Ljungman, M Boeckh, HH Hirsch… - Clinical Infectious …, 2016 - academic.oup.com
Cytomegalovirus (CMV) infection and disease are important causes of morbidity and
mortality in transplant recipients. For the purpose of developing consistent reporting of CMV …
mortality in transplant recipients. For the purpose of developing consistent reporting of CMV …
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
SR Goldsmith, MB Abid, JJ Auletta… - Blood, The Journal …, 2021 - ashpublications.org
Prior studies suggest increased cytomegalovirus (CMV) infection after haploidentical donor
transplantation with posttransplant cyclophosphamide (HaploCy). The role of allograft …
transplantation with posttransplant cyclophosphamide (HaploCy). The role of allograft …
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
P Teira, M Battiwalla, M Ramanathan… - Blood, The Journal …, 2016 - ashpublications.org
Single-center studies have reported an association between early (before day 100)
cytomegalovirus (CMV) reactivation and decreased incidence of relapse for acute myeloid …
cytomegalovirus (CMV) reactivation and decreased incidence of relapse for acute myeloid …
The pathogenesis of human cytomegalovirus
P Griffiths, I Baraniak, M Reeves - The Journal of pathology, 2015 - Wiley Online Library
Human cytomegalovirus (HCMV) is a recognized cause of disease in the fetus, the allograft
recipient and AIDS patients. More recently, it has been recognized as a pathogen for those …
recipient and AIDS patients. More recently, it has been recognized as a pathogen for those …
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
ML Green, W Leisenring, HU Xie, TC Mast… - The Lancet …, 2016 - thelancet.com
Background Although cytomegalovirus viral load is commonly used to guide pre-emptive
therapy in the post-transplantation setting, few data are available correlating viraemia with …
therapy in the post-transplantation setting, few data are available correlating viraemia with …